Vulnerable Plaque: Are Targeted Therapies Within Reach?
Rupture of unstable non-obstructive plaque is the underlying cause of most acute coronary syndromes. However, imaging tests to identify high-risk plaque features such as thin-cap fibroatheroma (TCFA) or spotty calcification are not practical for everyday use and have had mixed success for predicting future events.
Read more
April 2024
Surrey Cardiovascular Clinic and Caristo Diagnostics Launch Employee Heart Wellness and Disease Prevention Program for UK Employers
Caristo’s AI technology predicts heart attack risk for employee wellness initiative from respected centre of excellence OXFORD, England and SURREY, England , April 23,…
Read more
April 2024
American College of Cardiology Presentation Highlights Promising Results Showing Potential to Reduce Coronary Inflammation with Abcentra’s Orticumab
Caristo’s CaRi-Heart® AI Technology used to monitor effects of Orticumab detected a reduction in coronary inflammation and predicted a 50%…